Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

1.1K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

642
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

880
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

975
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
975

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disentangling Orbital and Confinement Contributions to <i>g</i>-Factor in Ge/SiGe Hole Quantum Dots.

Nano letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

A dressed singlet-triplet qubit in germanium.

Nature communications·2026
Same author

Search for New Physics in Jet Multiplicity Patterns of Multilepton Events at sqrt[s]=13  TeV.

Physical review letters·2025
Same author

Observation of Λ Hyperon Local Polarization in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2025
Same author

Search for a Neutral Gauge Boson with Nonuniversal Fermion Couplings in Vector Boson Fusion Processes in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2025

Related Experiment Video

Updated: Apr 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K

Personalization algorithms applied to cardiovascular disease risk assessment.

S Paredes, T Marques, T Rocha

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |January 9, 2015
    PubMed
    Summary

    Personalizing cardiovascular disease (CVD) risk assessment improves patient stratification. A similarity measures approach enhanced accuracy in identifying CVD risk, outperforming current tools for Acute Coronary Syndrome patients.

    More Related Videos

    Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
    08:21

    Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

    Published on: July 21, 2023

    2.2K
    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    2.4K

    Related Experiment Videos

    Last Updated: Apr 18, 2026

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
    07:51

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

    Published on: September 26, 2018

    8.2K
    Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
    08:21

    Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

    Published on: July 21, 2023

    2.2K
    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    2.4K

    Area of Science:

    • Cardiology
    • Medical Informatics
    • Health Services Research

    Background:

    • Cardiovascular disease (CVD) is a leading global cause of mortality.
    • Current clinical guidelines utilize risk assessment tools for patient CVD risk stratification.
    • Existing tools may exhibit variable performance across different patient populations.

    Purpose of the Study:

    • To explore personalized CVD risk assessment strategies.
    • To develop and validate patient grouping methodologies for enhanced risk prediction.
    • To compare the performance of novel personalization methods against existing CVD risk assessment tools.

    Main Methods:

    • Developed two patient personalization methods: a clustering approach and a similarity measures approach.
    • Validated these methodologies using data from 460 Portuguese Acute Coronary Syndrome with non-ST segment elevation (ACS-NSTEMI) patients.
    • Evaluated the sensitivity, specificity, and geometric mean of the proposed methods.

    Main Results:

    • The similarity measures approach demonstrated superior performance compared to the clustering method.
    • The similarity measures approach achieved a sensitivity of 77.7%, specificity of 63.2%, and geometric mean of 69.7%.
    • These results represent an improvement over the performance of current CVD risk assessment tools (78.5%, 53.2%, 64.4% respectively).

    Conclusions:

    • Personalized CVD risk assessment, particularly using similarity measures, can optimize patient stratification.
    • The similarity measures approach offers enhanced accuracy for CVD risk prediction in ACS-NSTEMI patients.
    • This study highlights the potential of tailored risk assessment to improve healthcare strategies for cardiovascular events.